Last reviewed · How we verify
NCT06277739
Brain Effect Mechanism of Spinal Manipulative Therapy on LDH Analgesia Based on Multimodal MRI
NA trial testing Spinal Manipulative Therapy in Lumbar Disc Herniation in 90 participants. Completed in 1 May 2025.
1 May 2025
Quick facts
| Lead sponsor | Zhou Xingchen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 1 June 2022 |
| Primary completion | 1 May 2025 |
| Estimated completion | 1 May 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Spinal Manipulative Therapy
- Sham Laser Treatment
Conditions studied
- Lumbar Disc Herniation — all drugs for Lumbar Disc Herniation →
Sponsor
Zhou Xingchen
Who can join
Adults 18 to 65, any sex, with Lumbar Disc Herniation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The clinical symptoms of Lumbar Disc Herniation (LDH) can be effectively ameliorated through Spinal Manipulative Therapy (SMT), which is closely linked to the brain's pain-regulating mechanisms. Magnetic Resonance Imaging (MRI) offers an objective and visual means to study how the brain orchestrates the characteristics of analgesic effects. From the perspective of multimodal MRI, the investigators applied functional MRI (fMRI) and Magnetic Resonance Spectrum (MRS) techniques to comprehensively evaluate the characteristics of the effects of SMT on the brain region of LDH from the aspects of brain structure, brain function and brain metabolism. This multimodal MRI technique provides a biological basis for the clinical application of SMT in LDH.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Impact of Spinal Manipulative Therapy on Brain Function and Pain Alleviation in Lumbar Disc Herniation: A Resting-State fMRI Study.
Zhou XC, Wu S, Wang KZ, Chen LH, et al · · 2025 · cited 5× · PMID 39707137 · DOI 10.1007/s11655-024-4205-7 -
Default mode network and dorsal attentional network connectivity changes as neural markers of spinal manipulative therapy in lumbar disc herniation.
Zhou XC, Wu S, Wang KZ, Chen LH, et al · · 2024 · cited 3× · PMID 39604454 · DOI 10.1038/s41598-024-81126-2
Verify or expand the search:
- PubMed search for NCT06277739
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Spinal Manipulative Therapy
Trials testing the same drug.
- NCT05996991 — The Impact of Positive, Neutral and Negative Expectation Speech on Manipulative Therapy Effects · NA · unknown
- NCT05202704 — Investigating the Hypoalgesic Effects of Manipulative Therapy Using Pain Conditioning and Expectations in Low Back Pain · NA · unknown
- NCT03361592 — The Immediate Effects of Spinal Manipulative Therapy on Kinetic and Kinematic Symmetry. · NA · completed
Other recruiting trials for Lumbar Disc Herniation
Currently open trials in the same condition.
- NCT07349719 — Dynamic Compliance-Guided Ventilation in Lumbar Surgery · NA · recruiting
- NCT07293676 — IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation · NA · recruiting
- NCT07184554 — Lumbar Disc Hernia, Erector Spinae Plane Block, Ilesi · NA · recruiting
- NCT06853132 — Baduanjin With Resistance Training Program · NA · recruiting
- NCT07085247 — The Role of Cutibacterium Acnes in the Development of Degenerative Lumbar Intervertebral Disc Disease · recruiting
Other Zhou Xingchen trials
Trials by the same sponsor.
- NCT06318156 — Exploring the Distribution Patterns and Infrared Characteristics of Force-sensitive Acupoints in Different Lumbar Nerve · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06277739 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhou Xingchen
- Last refreshed: 15 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06277739.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing